Use of these drugs can improve diabetes management without increasing risk for hypoglycemia (hypoglycemia is not strictly ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

In addition, the American Diabetes Association’s treatment guidelines recommend GLP-1 agonists (the drug class Ozempic and Victoza belong to) as a treatment option for adults with type 2 ...

Dr. Marion has assembled a team of high-profile, experienced pharmaceutical executives, former senior FDA members, and academic scientists to lead the development of PATAS. He has also established ...

(NewMediaWire) - November 11, 2024 - DALLAS GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the ...

GLP-1 medications, such as Ozempic, may interact with other drugs, causing very low blood sugar levels or disrupting the ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

Good news for people with diabetes who can enjoy better kidney health as well as ward off gout, thanks to a pioneering diabetes drug that can also cut the risk of kidney stones.A study published in ...

Drugs that belong to the class of GLP-1 receptor agonists could cause muscle loss ... and slow down digestion. These drugs ...